How to Get Ozempic Online Legally in 2026: Telehealth Rules, Insurance Coverage, and Compounded Alternatives

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Ozempic requires a valid prescription from a licensed provider, which can be obtained through telehealth platforms in all 50 states as of 2026 under permanent DEA telemedicine rules
• Most telehealth platforms cannot prescribe brand-name Ozempic directly due to manufacturer distribution restrictions, but can prescribe compounded semaglutide or facilitate traditional pharmacy fills
• Insurance rarely covers Ozempic prescribed through telehealth for weight loss (off-label use), but typically covers it for type 2 diabetes with prior authorization
• Compounded semaglutide through telehealth platforms costs $179 to $499 monthly without insurance, compared to $940+ for brand-name Ozempic cash price

Direct answer (40-60 words)

You can get Ozempic online by completing a telehealth consultation with a licensed provider who evaluates your medical history and determines if semaglutide is appropriate. The provider writes a prescription sent to a pharmacy of your choice. Most telehealth platforms offer compounded semaglutide rather than brand-name Ozempic due to distribution agreements, with monthly costs ranging from $179 to $499.

Table of contents

1. The three legal pathways to get Ozempic online
2. What most articles get wrong about online Ozempic prescriptions
3. How telehealth prescribing actually works (state-by-state rules)
4. Brand-name Ozempic vs compounded semaglutide through telehealth
5. The 5-step telehealth prescription process
6. Insurance coverage for telehealth-prescribed semaglutide
7. Cost comparison: telehealth platforms vs traditional providers
8. Red flags: when an online service is operating illegally
9. The FormBlends telehealth model
10. When you should NOT get Ozempic online
11. FAQ
12. Sources

The three legal pathways to get Ozempic online

Pathway 1: Telehealth consultation with traditional pharmacy fill. You complete a video or asynchronous visit with a licensed provider through a telehealth platform. The provider writes a prescription for brand-name Ozempic and sends it to your local pharmacy (CVS, Walmart, Walgreens). You pick it up in person or arrange delivery. Your insurance processes the claim normally.

This pathway works for patients who want brand-name Ozempic, have insurance that covers it, and live in states where the telehealth provider is licensed. The provider never touches the medication. They simply write the prescription.

Pathway 2: Telehealth consultation with compounded semaglutide delivery. You complete a telehealth visit. The provider writes a prescription for compounded semaglutide (not brand-name Ozempic). The prescription goes to a compounding pharmacy partnered with the telehealth platform. The pharmacy ships the compounded medication directly to your home.

This is the most common pathway for weight-loss-focused telehealth platforms because compounded semaglutide isn't subject to the same distribution restrictions as brand-name Ozempic, and the cash-pay pricing is predictable.

Pathway 3: Your existing provider writes a prescription during a telehealth visit. If you already have a relationship with a primary care provider or endocrinologist who offers telehealth visits, you can request Ozempic during a virtual appointment. The provider sends the prescription to your regular pharmacy. This is standard telemedicine, not a specialized platform.

All three pathways are legal under current federal and state telemedicine rules. The provider must be licensed in your state, must conduct a valid patient evaluation, and must document medical necessity.

What most articles get wrong about online Ozempic prescriptions

Most consumer health articles claim "you can order Ozempic online" without distinguishing between brand-name Ozempic and compounded semaglutide. This creates confusion because the two products follow completely different distribution models.

The error: Articles treat "getting Ozempic online" as a single process. They don't explain that Novo Nordisk (Ozempic's manufacturer) restricts brand-name Ozempic distribution to traditional pharmacy channels and prohibits direct-to-consumer shipment through most telehealth platforms.

The reality: When you use a telehealth weight-loss platform like Hims, Ro, or FormBlends, you're almost always receiving compounded semaglutide, not brand-name Ozempic. The platform can't ship you brand-name Ozempic directly because Novo Nordisk doesn't sell to compounding pharmacies or most telehealth-affiliated mail-order pharmacies.

A 2025 survey by the National Association of Boards of Pharmacy found that 68% of patients using telehealth weight-loss platforms believed they were receiving "Ozempic" when they were actually receiving compounded semaglutide (NABP Consumer Survey 2025). The clinical outcomes are similar, but the regulatory status, pricing, and insurance coverage are entirely different.

Why this matters: If you want brand-name Ozempic covered by insurance, you need Pathway 1 (telehealth consultation, traditional pharmacy fill). If you want affordable cash-pay semaglutide without insurance paperwork, you need Pathway 2 (compounded semaglutide). Conflating the two leads to surprise billing and unmet expectations.

How telehealth prescribing actually works (state-by-state rules)

The DEA made pandemic-era telemedicine flexibilities permanent in 2023, allowing providers to prescribe controlled substances (Schedule II-V) via telehealth without an in-person visit. Semaglutide (Ozempic, Wegovy, compounded versions) is not a controlled substance, so it faces fewer restrictions than medications like Adderall or opioids.

Federal baseline (applies in all states):

• The provider must be licensed in the state where the patient is physically located at the time of the consultation
• The provider must conduct a valid medical evaluation (video, phone, or asynchronous questionnaire, depending on state rules)
• The provider must establish a provider-patient relationship (definition varies by state)
• The prescription must be written for a legitimate medical purpose

State variations that affect online Ozempic access:

States requiring live video for initial visits (as of Q1 2026): Arkansas, Louisiana, Oklahoma, and Texas require synchronous video for the first telemedicine visit before prescribing weight-loss medications. Asynchronous (questionnaire-only) platforms don't operate in these states for new patients.

States with special informed consent rules: California, New York, and Illinois require explicit written informed consent for telemedicine visits that includes language about the limitations of remote evaluation. Most platforms auto-generate this during intake.

States with compounding-specific restrictions: Florida and Nevada have additional oversight rules for compounding pharmacies that ship across state lines. Platforms must use in-state compounding pharmacies or pharmacies with specific Florida/Nevada licenses.

States with no additional restrictions beyond federal baseline: The remaining 43 states allow asynchronous telemedicine for semaglutide prescriptions, accept out-of-state compounding pharmacy shipments, and don't require special consent forms beyond standard HIPAA documentation.

The practical impact: if you live in Arkansas, Louisiana, Oklahoma, or Texas, you'll need a live video visit (not just a questionnaire) to get semaglutide through telehealth. In all other states, most platforms offer asynchronous intake.

Brand-name Ozempic vs compounded semaglutide through telehealth

Feature	Brand-name Ozempic (telehealth Pathway 1)	Compounded semaglutide (telehealth Pathway 2)
FDA approval status	FDA-approved for type 2 diabetes	Not FDA-approved (compounded under 503A/503B exemptions)
Delivery method	Pre-filled pen, auto-injector	Vial with separate syringes, or pre-filled syringes
Prescription required	Yes, from licensed provider	Yes, from licensed provider
Insurance coverage	Common for diabetes, rare for weight loss	Almost never covered
Cash price	$940 to $1,150/month	$179 to $499/month
Manufacturer	Novo Nordisk	State-licensed compounding pharmacy
Direct home shipment	No (must go through traditional pharmacy)	Yes (ships from compounding pharmacy)
Dosing flexibility	Fixed pen doses (0.25, 0.5, 1, 2 mg)	Customizable (any dose provider prescribes)
Typical telehealth platform	Teladoc, MDLive, your existing provider	FormBlends, Hims, Ro, Eden, Henry Meds

The single biggest decision point: do you have insurance that covers Ozempic, and are you willing to navigate prior authorization? If yes, pursue brand-name Ozempic through Pathway 1. If no, or if your copay is over $200/month, compounded semaglutide through Pathway 2 is usually more affordable.

The 5-step telehealth prescription process

Here's what happens when you request Ozempic or semaglutide through a telehealth platform, using FormBlends as the reference model.

Step 1: Medical intake questionnaire (5 to 15 minutes). You answer questions about your medical history, current medications, weight-loss goals, BMI, previous weight-loss attempts, cardiovascular history, family history of thyroid cancer, and history of pancreatitis. The platform checks for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, breastfeeding).

Most platforms require a BMI of 27+ with a weight-related comorbidity (hypertension, prediabetes, sleep apnea) or a BMI of 30+ without comorbidities. Some platforms accept lower BMIs for patients with documented metabolic conditions.

Step 2: Provider review (same day to 48 hours). A licensed physician, nurse practitioner, or physician assistant reviews your intake. In synchronous-video states, you complete a live video visit. In asynchronous states, the provider reviews your questionnaire and may message you with follow-up questions.

The provider determines if semaglutide is medically appropriate. Approval rates vary by platform but typically run 70% to 85% for patients who meet BMI criteria and have no contraindications (internal FormBlends data, Q4 2025).

Step 3: Prescription generation. If approved, the provider writes a prescription. For brand-name Ozempic (Pathway 1), the prescription is sent electronically to the pharmacy you specified (CVS, Walgreens, local pharmacy). For compounded semaglutide (Pathway 2), the prescription goes to the platform's partner compounding pharmacy.

The prescription includes the specific dose, titration schedule, and number of refills. Most providers start at 0.25 mg weekly and titrate up every 4 weeks.

Step 4: Pharmacy fulfillment. For brand-name Ozempic, your local pharmacy processes the prescription through your insurance (if applicable) or quotes you the cash price. You pick it up or arrange delivery.

For compounded semaglutide, the compounding pharmacy prepares the medication, packages it with syringes and alcohol wipes, and ships it via temperature-controlled courier (usually FedEx or UPS with cold packs). Delivery takes 3 to 7 business days.

Step 5: Ongoing monitoring. Telehealth platforms typically require monthly check-ins (asynchronous questionnaire or brief video visit) to monitor side effects, weight-loss progress, and adherence. The provider adjusts the dose as needed. Refills are automatic as long as you remain medically appropriate for continued treatment.

The entire process from intake to first dose typically takes 3 to 10 days for compounded semaglutide, or 5 to 14 days for brand-name Ozempic (longer if prior authorization is required).

Insurance coverage for telehealth-prescribed semaglutide

Brand-name Ozempic prescribed through telehealth, filled at traditional pharmacy: Your insurance treats this identically to an in-person prescription. If your plan covers Ozempic for type 2 diabetes, it covers it regardless of whether the prescription came from a telehealth visit or an office visit. The same prior authorization requirements apply.

For weight loss (off-label Ozempic use), most commercial plans don't cover it. A 2025 KFF survey found that 87% of employer-sponsored plans exclude coverage for GLP-1 medications prescribed solely for weight loss (KFF Employer Health Benefits Survey 2025).

Compounded semaglutide prescribed through telehealth: Insurance almost never covers compounded medications. Compounded semaglutide is not FDA-approved, doesn't have an NDC code that insurance systems recognize, and isn't included in formularies.

Patients pay cash. The platform typically bundles the provider visit, prescription, medication, and supplies into a single monthly subscription fee.

Reimbursement strategies: Some patients submit a superbill (itemized receipt) to their insurance for out-of-network reimbursement. Success rates are low (under 10% based on anecdotal reports), but patients with PPO plans and out-of-network benefits occasionally recover 30% to 50% of the cost.

FSA and HSA funds can be used to pay for telehealth-prescribed compounded semaglutide because it's a prescription medication for a diagnosed medical condition (obesity, prediabetes). This is the most reliable form of "insurance" involvement for compounded products.

Cost comparison: telehealth platforms vs traditional providers

Traditional in-person provider, brand-name Ozempic:

• Office visit copay: $20 to $75
• Ozempic copay (with insurance): $25 to $500/month (see our Walmart cost breakdown at /articles/cost-guides/ozempic-cost-at-walmart-with-insurance-what-youll-actually-pay/)
• Ozempic cash price (without insurance): $940 to $1,150/month
• Total first-month cost (insured): $45 to $575
• Total first-month cost (uninsured): $960 to $1,225

Telehealth platform, brand-name Ozempic (Pathway 1):

• Platform visit fee: $0 to $49 (many platforms waive this if you fill the prescription)
• Ozempic copay (with insurance): $25 to $500/month (same as traditional)
• Ozempic cash price (without insurance): $940 to $1,150/month (same as traditional)
• Total first-month cost: comparable to traditional provider

Telehealth platform, compounded semaglutide (Pathway 2):

• Platform monthly subscription (includes visit, prescription, medication, supplies): $179 to $499
• No insurance involvement, no copay, no deductible
• Total first-month cost: $179 to $499
• Total ongoing monthly cost: $179 to $499 (some platforms reduce price after first 3 months)

FormBlends pricing (as of Q1 2026):

• Compounded semaglutide: $179 to $279/month depending on dose
• Compounded tirzepatide: $299 to $399/month depending on dose
• Includes provider visits, prescription, medication, syringes, alcohol wipes, and sharps container
• No hidden fees, no insurance required

The cost advantage of telehealth is most pronounced for uninsured patients or patients whose insurance doesn't cover semaglutide for weight loss. For insured patients with low copays (under $100/month), brand-name Ozempic through a traditional provider may be cheaper than telehealth compounded semaglutide.

Red flags: when an online service is operating illegally

Not all "get Ozempic online" services follow state and federal prescribing laws. Here are the red flags that indicate a platform is operating outside legal boundaries.

Red flag 1: No provider evaluation required. Any platform that ships semaglutide without a provider reviewing your medical history is violating federal prescribing laws. A valid prescription requires a provider-patient relationship and a medical evaluation. A questionnaire alone isn't sufficient unless a licensed provider reviews and approves it.

Red flag 2: Provider not licensed in your state. The provider who writes your prescription must hold an active license in the state where you're physically located. Platforms that use a single provider licensed in one state to prescribe to patients nationwide are violating state medical practice laws.

Red flag 3: Shipping from outside the U.S. Compounded semaglutide must be prepared by a U.S.-based, state-licensed compounding pharmacy operating under FDA 503A or 503B rules. Platforms that ship from international pharmacies (Canada, India, Mexico) are importing unapproved drugs, which is illegal.

Red flag 4: No pharmacy information disclosed. Legitimate platforms disclose which compounding pharmacy prepares the medication. If the platform won't tell you the pharmacy name, state license number, or physical address, the medication may be coming from an unlicensed source.

Red flag 5: Claims that compounded semaglutide is "the same as Ozempic." Compounded semaglutide is not FDA-approved and is not interchangeable with brand-name Ozempic. Platforms that claim equivalency are making false statements. Legitimate platforms explain the difference clearly.

Red flag 6: Prescribing to patients under 18. Semaglutide is not FDA-approved for weight loss in patients under 18 (Wegovy is approved for ages 12+ with obesity, but most telehealth platforms don't serve pediatric patients). Platforms prescribing to minors without specialized pediatric oversight are operating outside standard-of-care guidelines.

Red flag 7: No ongoing monitoring. Safe semaglutide prescribing requires regular follow-up to monitor side effects, adjust doses, and check for complications. Platforms that ship refills automatically without any provider check-in are not meeting the standard of care.

If you encounter any of these red flags, don't use the service. Report it to your state medical board or the FDA's MedWatch program.

The FormBlends telehealth model

FormBlends connects patients with U.S.-licensed providers and state-licensed compounding pharmacies for compounded GLP-1 medications (semaglutide and tirzepatide).

How it works:

1. You complete a medical intake questionnaire covering weight history, comorbidities, contraindications, and current medications.
2. A licensed provider (physician, NP, or PA) reviews your intake within 24 hours. In states requiring synchronous visits, you schedule a brief video call.
3. If approved, the provider writes a prescription for compounded semaglutide or tirzepatide at the appropriate starting dose.
4. The prescription goes to our partner 503A compounding pharmacy, which prepares the medication in a sterile environment and ships it to your address with syringes and supplies.
5. You receive monthly check-ins from your provider to monitor progress, adjust dosing, and address side effects.

What we see most often in our prescription approval patterns: About 78% of patients who complete intake are approved for treatment on first review. The most common reasons for non-approval are active gallbladder disease (14% of denials), personal history of medullary thyroid carcinoma or MEN2 (6%), pregnancy or breastfeeding (4%), and BMI below our clinical threshold without documented metabolic comorbidity (3%). Among approved patients, approximately 85% start on semaglutide rather than tirzepatide due to lower cost and established safety profile. The median time from intake to first injection is 6 days. These patterns come from our internal clinical data across 4,200+ patient onboardings between Q2 2025 and Q1 2026.

Pricing:

• Compounded semaglutide: $179/month (starting dose) to $279/month (maintenance dose)
• Compounded tirzepatide: $299/month (starting dose) to $399/month (maintenance dose)
• No additional fees for provider visits, shipping, or supplies

What's included:

• Unlimited provider messaging
• Monthly dose adjustments as needed
• Pre-filled syringes or vials (depending on dose and availability)
• Alcohol wipes and sharps container
• Temperature-controlled shipping

FormBlends operates in 48 states (excluding Arkansas and Louisiana due to synchronous-visit requirements we're building capacity for). All providers are U.S.-licensed and board-certified. All compounding pharmacies are state-licensed, FDA-registered, and inspected regularly.

When you should NOT get Ozempic online

Telehealth is not appropriate for every patient seeking semaglutide. Here are the clinical situations where an in-person evaluation is necessary.

You have a complex medical history that requires physical examination. If you have uncontrolled hypertension, recent cardiovascular events (heart attack, stroke in the past 6 months), severe kidney disease (eGFR under 30), or active liver disease, a provider needs to examine you in person, review recent labs, and potentially consult with specialists before starting semaglutide.

Telehealth platforms typically exclude patients with these conditions during intake, but some patients underreport or don't recognize the severity of their conditions. If your medical history is complicated, start with your primary care provider.

You need insurance coverage for brand-name Ozempic. If you want your insurance to cover Ozempic for type 2 diabetes, you may get faster prior authorization approval by working with an in-person endocrinologist who has an established relationship with your insurance company and can provide detailed documentation.

Telehealth providers can submit prior authorizations, but some insurance companies are slower to approve PAs from telehealth providers they don't have existing relationships with. This is improving, but it's still a friction point as of 2026.

You're using semaglutide as part of bariatric surgery preparation. Patients preparing for bariatric surgery often use GLP-1 medications for pre-surgical weight loss. This requires coordination between the bariatric surgeon, anesthesiologist, and prescribing provider. Telehealth platforms aren't set up for this level of care coordination.

You have a history of severe GI complications. If you've had gastroparesis, chronic pancreatitis, inflammatory bowel disease, or bowel obstruction, semaglutide may worsen these conditions. These situations require in-person gastroenterology consultation before starting a GLP-1 medication.

You're pregnant, trying to conceive, or breastfeeding. Semaglutide is contraindicated in pregnancy and should be stopped at least 2 months before attempting conception. Telehealth platforms exclude pregnant and breastfeeding patients, but if you're actively trying to conceive, you need in-person reproductive endocrinology guidance.

You prefer the oversight of a long-term provider relationship. Some patients feel more comfortable with a provider they see in person regularly, who knows their full medical history, and who can address multiple health concerns in a single visit. Telehealth is transactional by design. If you value longitudinal relationship-based care, stick with your in-person provider.

The decision tree: if you're a healthy adult with obesity or overweight with comorbidities, no contraindications, and you're comfortable with remote care, telehealth is safe and effective. If you have multiple chronic conditions, complex medication regimens, or need hands-on medical management, start in person.

FAQ

Can I legally get Ozempic online without seeing a doctor in person? Yes. Federal telemedicine rules allow providers to prescribe semaglutide via telehealth (video or asynchronous questionnaire) without an in-person visit. The provider must be licensed in your state and must conduct a valid medical evaluation. Four states (Arkansas, Louisiana, Oklahoma, Texas) require live video for the initial visit.

Is online Ozempic the same as pharmacy Ozempic? If you get a prescription through telehealth and fill it at a traditional pharmacy (CVS, Walmart), it's the same brand-name Ozempic. If you get compounded semaglutide through a telehealth platform, it's not the same product. Compounded semaglutide contains the same active ingredient but is not FDA-approved and is prepared by a compounding pharmacy rather than manufactured by Novo Nordisk.

How much does it cost to get Ozempic online? Telehealth visit fees range from $0 to $49. If you're getting brand-name Ozempic filled at a pharmacy, the medication cost is $25 to $500/month with insurance or $940+ without insurance. If you're getting compounded semaglutide through a telehealth platform, the all-in monthly cost is $179 to $499 including the visit, prescription, and medication.

Will my insurance cover Ozempic prescribed online? If the prescription is for brand-name Ozempic and your plan covers Ozempic for type 2 diabetes, yes. The insurance company doesn't distinguish between telehealth and in-person prescriptions. If the prescription is for compounded semaglutide, insurance almost never covers it.

How long does it take to get Ozempic through telehealth? From intake to first dose, expect 3 to 10 days for compounded semaglutide (shipped directly to you) or 5 to 14 days for brand-name Ozempic (longer if prior authorization is required). Provider review typically happens within 24 to 48 hours.

Do I need a video call to get Ozempic online? In most states, no. You can complete an asynchronous questionnaire and the provider reviews it without a live video call. Arkansas, Louisiana, Oklahoma, and Texas require synchronous video for the initial visit. Some platforms offer video calls as an option even in states that don't require it.

Can I get Ozempic online if I don't have diabetes? Yes, if you meet the criteria for off-label weight-loss use (BMI 27+ with comorbidity or BMI 30+). The provider prescribes it for obesity or weight management, not for diabetes. Insurance rarely covers this off-label use, so most patients pay cash for compounded semaglutide.

Is it safe to get Ozempic from an online pharmacy? Only if the pharmacy is U.S.-based, state-licensed, and FDA-registered. Avoid international online pharmacies that ship from outside the U.S. These are often selling counterfeit or improperly stored medications. Legitimate telehealth platforms disclose their pharmacy partners and provide state license numbers.

What's the difference between Ozempic and Wegovy online? Ozempic and Wegovy both contain semaglutide. Ozempic is FDA-approved for type 2 diabetes (doses up to 2 mg). Wegovy is FDA-approved for weight loss (doses up to 2.4 mg). Most telehealth platforms prescribe compounded semaglutide at Wegovy-equivalent doses for weight loss rather than prescribing brand-name Wegovy or off-label Ozempic.

Can I use a telehealth platform if I already have a doctor? Yes. You don't need to choose between your existing provider and a telehealth platform. Some patients use their primary care provider for general health and a telehealth platform specifically for weight-loss medication because it's more affordable or convenient. Just make sure both providers know about all your medications to avoid drug interactions.

Do telehealth platforms prescribe Ozempic for weight loss? Most telehealth weight-loss platforms prescribe compounded semaglutide rather than brand-name Ozempic for weight loss. Compounded semaglutide is cheaper and doesn't require insurance prior authorization. A few platforms will write a prescription for brand-name Ozempic or Wegovy if you specifically request it and plan to fill it at a traditional pharmacy with your insurance.

What happens if I have side effects from online-prescribed Ozempic? Contact your telehealth provider immediately through the platform's messaging system. Most platforms offer 24/7 provider access for urgent issues. The provider can adjust your dose, prescribe anti-nausea medication, or discontinue treatment if side effects are severe. For emergencies (severe abdominal pain, signs of pancreatitis, allergic reaction), go to the ER and inform them you're taking semaglutide.

Sources

1. National Association of Boards of Pharmacy. Consumer Survey on Telehealth Weight-Loss Services. 2025.
2. Kaiser Family Foundation. Employer Health Benefits Survey: Coverage of GLP-1 Medications. 2025.
3. Drug Enforcement Administration. Permanent Telemedicine Flexibilities for Controlled and Non-Controlled Substances. Federal Register. 2023.
4. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
5. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.
6. Novo Nordisk. Ozempic Prescribing Information. 2024.
7. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2024.
8. Centers for Medicare & Medicaid Services. Medicare Coverage of GLP-1 Receptor Agonists. 2025.
9. American Telemedicine Association. State Telemedicine Policy Resource Center. 2026.
10. Federation of State Medical Boards. Model Policy for the Appropriate Use of Telemedicine Technologies. 2022.
11. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.
12. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
13. Wadden TA et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021.
14. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. 1998 (updated 2024).

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Walmart, CVS, Walgreens, Costco, GoodRx, Teladoc, and MDLive are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.